BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 5, 2005
View Archived Issues
Neuro3d's Third Round: EUR31.5M For Development Of Lead Drugs
PARIS - Neuro3d closed a third round of financing in which it raised €31.5 million (US$41.6 million) from eight European venture capital funds. (BioWorld International)
Read More
Arrow Spins Out Immunoprime To Focus On Infectious Disease
Read More
New Study Highlights Cell Cycle Regulation Intricacy
Read More
BioAlliance Pharma To File In EU For Miconazole Lauriad Approval
Read More
Stem Cell Foundation Planned To Help Bridge UK Funding Gap
Read More
Other News To Note
Read More